| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5955(99)00193-8 |
| P698 | PubMed publication ID | 10675648 |
| P2093 | author name string | Miller JM | |
| Prieskorn DM | |||
| P2860 | cites work | Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma | Q40993628 |
| In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody | Q42438911 | ||
| KHRI-3 monoclonal antibody-induced damage to the inner ear: antibody staining of nascent scars | Q42470175 | ||
| Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. | Q46183250 | ||
| Chronic drug infusion into the scala tympani of the guinea pig cochlea | Q46306545 | ||
| Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss | Q46308775 | ||
| Osmotic pump implant for chronic infusion of drugs into the inner ear. | Q50527450 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | technical report | Q3099732 |
| P304 | page(s) | 212-215 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Hearing Research | Q3040317 |
| P1476 | title | Technical report: chronic and acute intracochlear infusion in rodents. | |
| P478 | volume | 140 |
| Q50487278 | A model for perilymphatic fistula induced hearing loss in the guinea pig cochlea. |
| Q44441757 | A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function |
| Q48475948 | A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion. |
| Q44619665 | Adenoviral vector gene delivery via the round window membrane in guinea pigs |
| Q43169212 | Antioxidant gene therapy can protect hearing and hair cells from ototoxicity |
| Q42452622 | Biodegradable polymeric coatings on cochlear implant surfaces and their influence on spiral ganglion cell survival |
| Q30472996 | Biomaterials in cochlear implants |
| Q48540796 | Brain-derived neurotrophic factor treatment does not improve functional recovery after hair cell regeneration in the pigeon |
| Q37018361 | Cochlear perfusion with a viscous fluid |
| Q58081938 | Comparison of the distribution pattern of PEG-b-PCL polymersomes delivered into the rat inner ear via different methods |
| Q46791406 | Deafferentation-associated changes in afferent and efferent processes in the guinea pig cochlea and afferent regeneration with chronic intrascalar brain-derived neurotrophic factor and acidic fibroblast growth factor. |
| Q45062512 | Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs |
| Q40865835 | Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss |
| Q30476020 | Drug delivery for treatment of inner ear disease: current state of knowledge |
| Q30474860 | Electromotile hearing: acoustic tones mask psychophysical response to high-frequency electrical stimulation of intact guinea pig cochleae |
| Q35750247 | Exogenous BDNF rescues rat spiral ganglion neurons in vivo |
| Q26851920 | Gene therapy for the inner ear |
| Q30487438 | Glutamatergic neuronal differentiation of mouse embryonic stem cells after transient expression of neurogenin 1 and treatment with BDNF and GDNF: in vitro and in vivo studies |
| Q50473508 | In vitro and in vivo suppression of GJB2 expression by RNA interference. |
| Q30484636 | Inner ear drug delivery for auditory applications |
| Q30500338 | Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. |
| Q44063777 | Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. |
| Q44509560 | Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig. |
| Q30464082 | Intracochlear drug delivery systems |
| Q35784070 | Jun N-terminal protein kinase enhances middle ear mucosal proliferation during bacterial otitis media |
| Q30466728 | Kinetics of reciprocating drug delivery to the inner ear |
| Q30489671 | Local inner-ear drug delivery and pharmacokinetics. |
| Q30475885 | Localized cell and drug delivery for auditory prostheses. |
| Q30425077 | MED-EL Cochlear implants: state of the art and a glimpse into the future |
| Q89824565 | MRI detection of endolymphatic hydrops in Meniere's disease in 8 minutes using MIIRMR and a 20-channel coil after targeted gadolinium delivery |
| Q44346585 | Mechanism of electrical stimulation-induced neuroprotection: effects of verapamil on protection of primary auditory afferents |
| Q33866367 | Nanofibrous scaffolds for the guidance of stem cell-derived neurons for auditory nerve regeneration. |
| Q45183282 | Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. |
| Q48029892 | Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin |
| Q30828850 | Persistence, distribution, and impact of distinctly segmented microparticles on cochlear health following in vivo infusion |
| Q33491736 | Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules |
| Q28743455 | Protective role of hydrogen sulfide against noise-induced cochlear damage: a chronic intracochlear infusion model |
| Q45407743 | Sendai virus vector-mediated transgene expression in the cochlea in vivo |
| Q37271376 | State-of-the-art mechanisms of intracochlear drug delivery. |
| Q30487720 | Stem cell transplantation for auditory nerve replacement |
| Q50483729 | Systemic co-treatment with α-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs |
| Q46965179 | The pharmacokinetic profiles of dexamethasone and methylprednisolone concentration in perilymph and plasma following systemic and local administration |
| Q38262931 | The role of intracochlear drug delivery devices in the management of inner ear disease |
Search more.